University of Alabama, Birmingham
Also known as: Alabama Infectious Disease Center | Alabama Therapeutics CRS | Alabama Vaccine Research Clinic, University of Alabama at Birmingham | Alan Tita | Andrew McDonald | Boni Elewski, MD | Breast Cancer Research Foundation of Alabama | Cardiology Department - University of Alabama at Birmingham | Centre for Infectious Disease Research in Zambia/University of Alabama Birmingham | Charles Mel Wilcox, MD | Children's Health System, Alabama | Children's Hospital of Alabama | Children's of Alabama | Comprehensive Cancer Center, University of Alabama at Birmingham | Department of Obstetrics and Gynecology, University of Alabama at Birmingham | Department of Pharmacology and Toxicology, University of Alabama at Birmingham | Department of Radiology, University of Alabama, Birmingham, AL | Division of Gastroenterology and Hepatology, UAB, Birmingham, AL, USA | Division of Gynecologic Oncology at University of Alabama at Birmingham | Division of Infectious Diseases University of Alabama at Birmingham | Divison of Gynecologic Oncology at University of Alabama at Birmingham | Francisco Robert,MD | Gorgas Memorial Institute for Health Studies | Institute of Clinical Research - Birmingham | Martina Bebin | Neurology Chair Office - University of Alabama at Birmingham | REACT Center | Southern College of Optometry | St. Vincent's East, Birmingham, Alabama | The Kirklin Clinic of UAB Hospital | The Kirklin Clinic, USA | The University of Alabama at Birmingham | The University of Alabama at Birmingham Department of Physical Medicine and Rehabilitation | UAB Center for AIDS Research | UAB Centre for AIDS Research, Birmingham, Alabama, 35294-2050, USA | UAB, CIDRZ | UAB Department of Anesthesiology, Critical Care Division | UAB Department of Pediatrics | UAB Dermatology Clinical Research | UAB, Div. of Infectious Diseases | UAB Liver Center, Division of Gastroenterology & Hepatology | UAB Medical Center, AIDS Outpatient Clinic, Birmingham, AL | UAB Pediatric Critical Care | UAB Resource Centers for Minority Aging Research (RCMAR) | UAB School of Optometry | UAB School of Public Health Department of Health Behavior | UNIV ALAHAMA BIRM | Univerisity of Alabama at Birmingham | Univeristy of Alabama at Birmingham | Univeristy of Alabama-Birmingham School of Medicine, Division of Neurology | University of Alabama and Birmingham | University of Alabama at Birmingham | University of Alabama at Birmingham, Birmingham, AB, US | University of Alabama at Birmingham Cancer Center | University of Alabama at Birmingham - Center for Clinical and Translational Science | University of Alabama at Birmingham, Comprehensive Cancer Ctr. | University of Alabama at Birmingham, Department of Psychiatry | University of Alabama at Birmingham, Department of Surgery | University of Alabama at Birmingham/Dermatology | University of Alabama at Birmingham Lung Health Center | University of Alabama at Birmingham, NFCTC | University of Alabama at Birmingham (no longer employee) | University of Alabama at Birmingham Pediatric Cardiac Critical Care | University of Alabama at Birmingham School of Optometry | University of Alabama at Birmingham School of Public Health, Department of Biostatistics | University of Alabama at Birmingham (UAB) | University of Alabama at Birmingham, USA | University of Alabama at Birminham | University of Alabama Birmingham Pediatric Eye Care, Birmingham Health Care | University of Alabama in Birmingham | University ot Alabama at Birmingham | Univ of Alabama at Birmingham | Univ. of Alabama at Birmingham | Wayne Sullender, M.D.
Highest phase reached
Phase 4
Timeline
1960s
- Nov 1, 1966
University of Alabama, Birmingham— Founded
2020s
- Nov 3, 2022
ammonia n-13— Marketing Organization
Drugs by trial phase (557 distinct, 678 trials)
Phase 4 (110 own, 0 via acquisition)
Phase 3 (92 own, 0 via acquisition)
Phase 2 (202 own, 0 via acquisition)
Phase 1 (94 own, 0 via acquisition)
Indications
Studied for
- Abruptio Placentae
- Acidosis
- Acidosis, Respiratory
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Acute Disease
- Acute Kidney Injury
- Acute Pain
- Adenocarcinoma
- Adenoma
- Adenoviridae Infections
- Albuminuria
- alpha 1-Antitrypsin Deficiency
- Alzheimer Disease
- Anemia
- Anemia, Aplastic
- Anemia, Diamond-Blackfan
- Anemia, Sickle Cell
- Angina, Unstable
- Ankle Fractures
- Anthrax
- Apnea
- Arthritis
- Arthritis, Experimental
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Astrocytoma
- Atrophic Vaginitis
- Atrophy
- Atypical Squamous Cells of the Cervix
- Basal Cell Carcinoma
- Birth Weight
- Bisphosphonate-Associated Osteonecrosis of the Jaw
- Blastomycosis
- Blepharitis
- Body Weight
- Borderline Personality Disorder
- Brain Diseases
- Brain Edema
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Neoplasms
- Breast Neoplasms
- Bronchitis
- Bronchitis, Chronic
- Bronchopulmonary Dysplasia
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinosarcoma
- Cardiovascular Diseases
- Central Nervous System Diseases
- Central Nervous System Neoplasms
- Cerebellar Neoplasms
- Cerebral Infarction
- Cerebral Palsy
- Chest Pain
- Chorioamnionitis
- Chronic Disease
- Cocaine-Related Disorders
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Connective Tissue Diseases
- Coronary Disease
- Critical Illness
- Crohn Disease
- Cystic Fibrosis
- Cystitis
- Cystitis, Interstitial
- Cystocele
- Cytomegalovirus Infections
- Deafness
- Death
- Delirium
- Depression
- Depressive Disorder
- Dermatitis
- Dermatitis, Seborrheic
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Disease
- Drug Resistant Epilepsy
- Dry Eye Syndromes
- Ductus Arteriosus, Patent
- Dyslipidemias
- Dysthymic Disorder
- Eclampsia
- Edema
- Emphysema
- Endocrine Gland Neoplasms
- Endometrial Neoplasms
Marketed drugs (1)
Recent trials (50)
- NCT06881888OfficialPhase 1Aug 31, 2026
- NCT06881888Lead sponsorPhase 1Aug 31, 2026
- NCT06881888Sponsor investigatorPhase 1Aug 31, 2026
- NCT07285473Lead sponsorPhase 2Apr 1, 2026
- NCT07285473OfficialPhase 2Apr 1, 2026
- NCT07285473Sponsor investigatorPhase 2Apr 1, 2026
- NCT07224529Lead sponsorPhase 4Feb 1, 2026
- NCT07224529Sponsor investigatorPhase 4Feb 1, 2026
- NCT07266571Lead sponsorN/AFeb 1, 2026
- NCT07266571OfficialN/AFeb 1, 2026
- NCT07266571Sponsor investigatorN/AFeb 1, 2026
- NCT07250854Sponsor investigatorEarly Phase 1Dec 31, 2025
- NCT07250854OfficialEarly Phase 1Dec 31, 2025
- NCT07250854Lead sponsorEarly Phase 1Dec 31, 2025
- NCT07135453Sponsor investigatorPhase 4Dec 31, 2025
Details
- Founded
- Birmingham, Alabama, US Nov 1, 1966
- Last known activity
- Aug 31, 2026